Metoprolol Succinate
NDC Package 69189-0830-5

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Metoprolol Succinate is a medication a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Marketed by Avera Mckennan Hospital, this product is identified by NDC 69189-0830 and is authorized under FDA application ANDA077118.

Identification & Billing

NDC Package Code
69189-0830-5
Package Description
.5 TABLET, FILM COATED, EXTENDED RELEASE in 1 DOSE PACK
Product Code
69189-0830
11-Digit Billing Format
69189083005

Clinical Specifications

Proprietary Name
Metoprolol Succinate
Dosage Form
-
Usage Information
This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

Regulatory & Marketing

Labeler Name
Avera Mckennan Hospital
FDA Application #
ANDA077118
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-09-2015
End Marketing Date
05-24-2017
Listing Expiration
05-24-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69189-0830-5 identifies a specific commercial package of .5 tablet, film coated, extended release in 1 dose pack of Metoprolol Succinate, labeled by Avera Mckennan Hospital. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Avera Mckennan Hospital on March 09, 2015. The current certification is valid through May 24, 2017.

What are the primary indications for this medication?

This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

How is this Avera Mckennan Hospital product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69189083005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
69189-0830-5
11-Digit CMS (5-4-2)
69189-0830-05

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.